The Cardiometabolic Effects of Menopause

Obstet Gynecol. 2026 Sep 4. doi: 10.1097/AOG.0000000000006418. Online ahead of print.ABSTRACTCardiovascular disease (CVD) remains the leading cause of death among women, yet CVD risk is frequently underrecognized during midlife, when the menopause transition is accompanied by significant biological

J Jana Karam

Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association

Circulation. 2026 Sep 3. doi: 10.1161/CIR.0000000000001476. Online ahead of print.ABSTRACTAIM: The American College of Cardiology/American Heart Association Scientific Statement, "Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities," was written to provide

E Elizabeth H Dineen

Diagnostic performance of computed tomography-derived fractional flow reserve in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: a single-centre feasibility study

Cardiovasc J Afr. 2026 Aug 28;37(3):375-380. doi: 10.5830/CVJA-2026-032. Epub 2026 Aug 28.ABSTRACTOBJECTIVE: Coronary artery disease (CAD) is prevalent in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). Computed tomography-derived fractional flow

S Soner Aksüyek

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry")

Lupus. 2026 Sep 3:9612033261479899. doi: 10.1177/09612033261479899. Online ahead of print.ABSTRACTObjectiveWhile triple antiphospholipid antibody (aPL) positivity is associated with a higher risk of thrombosis, the clinical significance of single aPL positivity remains unclear. This study aimed to a

S Silvia Grazietta Foddai